ROCHE CARDIAC TROP T 07007302190

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2019-01-24 for ROCHE CARDIAC TROP T 07007302190 manufactured by Roche Diagnostics.

Event Text Entries

[134081897] The event occurred in (b)(6).
Patient Sequence No: 1, Text Type: N, H10


[134081898] The customer received questionable roche cardiac poc troponin t results from a cobas h232 meter serial number (b)(4). The cobas h232 meter is not approved for distribution nor is like or similar to a product approved for distribution in the united states. The customer tested 4 different heparinized blood samples from a patient that presented with suspected coronary syndrome on a cobas h232 and compared the results to the troponin t high sensitivity results from a cobas 6000 e 601 module. Sample a troponin t result from the cobas h232 was 583 pg/ml with a data flag. The troponin t result from the cobas e602 was 3. 1 pg/ml. Sample b troponin t result from the cobas h232 was 663 pg/ml with a data flag. The troponin t result from the cobas e602 was < 3 pg/ml. Sample c troponin t result from the cobas h232 was 1033 pg/ml with a data flag. The troponin t result from the cobas e602 was < 3 pg/ml. Sample d troponin t result from the cobas h232 was 715 pg/ml with a data flag. The troponin t result from the cobas e602 was 3. 5 pg/ml. The erroneous results were reported outside of the laboratory. According to the customer, based on the electrocardiogram (ecg) testing and the ck and ck-mb data obtained, the data did not fit an acute infarction diagnosis. The emergency room physician administered heparin, morphine, aspirin, vomex, sterofundin, and nitro lingual spray. The customer stated this is standard therapy that they give to anyone suspected of having a heart attack. There was no information provided to reasonably suggest that the patient was adversely affected by the treatment. Clarification has been requested. The patient stated that they have been healthy and only recently taken an unspecified antibiotic. Qc results were acceptable. The cobas h232 and the troponin test strips have been requested for return. The investigation is currently ongoing.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1823260-2019-00262
MDR Report Key8274972
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2019-01-24
Date of Report2019-03-15
Date of Event2019-01-06
Date Mfgr Received2019-01-07
Date Added to Maude2019-01-24
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNA MICHAEL LESLIE
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175214343
Manufacturer G1ROCHE DIAGNOSTICS GMBH
Manufacturer StreetSANDHOFERSTRASSE 116 NA
Manufacturer CityMANNHEIM (BADEN-WURTTEMBERG) 68305
Manufacturer CountryGM
Manufacturer Postal Code68305
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameROCHE CARDIAC TROP T
Generic NameIMMUNOASSAY METHOD, TROPONIN SUBUNIT
Product CodeMMI
Date Received2019-01-24
Model NumberNA
Catalog Number07007302190
Lot Number35654411
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 462500457 US 462500457


Patients

Patient NumberTreatmentOutcomeDate
10 2019-01-24

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.